309 results on '"Chin, Koei"'
Search Results
2. Multiplex imaging of localized prostate tumors reveals altered spatial organization of AR-positive cells in the microenvironment
3. MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer
4. Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer.
5. A framework for multiplex imaging optimization and reproducible analysis
6. The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
7. cmIF: A Python Library for Scalable Multiplex Imaging Pipelines
8. Oligonucleotide conjugated antibody strategies for cyclic immunostaining
9. Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors
10. Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA
11. Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies
12. Abstract C087: Window-of-opportunity trial of metastatic pancreatic cancer reveals mechanisms of response to targeting RAS signaling
13. Abstract A115: Collective invasion facilitates liver metastasis in pancreatic ductal adenocarcinoma
14. Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment
15. Deregulating MYC in a model of [HER2.sup.+] breast cancer mimics human intertumoral heterogeneity
16. Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
17. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
18. A Screen for Genes That Suppress Loss of Contact Inhibition: Identification of ING4 as a Candidate Tumor Suppressor Gene in Human Cancer
19. Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ
20. Longitudinal and multimodal auditing of tumor adaptation to CDK4/6 inhibitors in HR+ metastatic breast cancers
21. A Neural Survival Factor Is a Candidate Oncogene in Breast Cancer
22. End-Sequence Profiling: Sequence-Based Analysis of Aberrant Genomes
23. Performance of Molecular Inversion Probes (MIP) in Allele Copy Number Determination
24. RESTORE: Robust intEnSiTy nORmalization mEthod for multiplexed imaging
25. Analysis of molecular inversion probe performance for allele copy number determination
26. Quantitative Analysis of Chromosomal CGH in Human Breast Tumors Associates Copy Number Abnormalities with p53 Status and Patient Survival
27. Simultaneous Detection of RNAs and Proteins with Subcellular Resolution
28. Cyclic Multiplexed-Immunofluorescence (cmIF), a Highly Multiplexed Method for Single-Cell Analysis
29. Breast tumor copy number aberration phenotypes and genomic instability
30. In situ quantification of genomic instability in breast cancer progression
31. Genetic Analysis Using Genomic Representations
32. cmIF: A Python Library for Scalable Multiplex Imaging Pipelines
33. Abstract 5630: Robust spatial biomarker discovery through multi-platform multiplex image analysis of breast cancer clinical cohorts
34. Supplementary Tables 1-7 from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System
35. Supplementary Methods and Figures 1-5 from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System
36. Data from Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System
37. Data from Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression
38. Supplementary Data from Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression
39. Data from A Human Breast Cell Model of Preinvasive to Invasive Transition
40. Data from An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays
41. Supplementary Figure 5 from A Human Breast Cell Model of Preinvasive to Invasive Transition
42. Supplementary Figure 4 from A Human Breast Cell Model of Preinvasive to Invasive Transition
43. Supplementary Figure 2 from A Human Breast Cell Model of Preinvasive to Invasive Transition
44. Supplementary Methods and Materials from A Human Breast Cell Model of Preinvasive to Invasive Transition
45. Supplementary Figure 6 from A Human Breast Cell Model of Preinvasive to Invasive Transition
46. Supplementary Figure 7 from A Human Breast Cell Model of Preinvasive to Invasive Transition
47. Supplementary Data URL from An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays
48. Supplementary Figure 1 from A Human Breast Cell Model of Preinvasive to Invasive Transition
49. Supplementary Figure 3 from A Human Breast Cell Model of Preinvasive to Invasive Transition
50. Robust biomarker discovery through multiplatform multiplex image analysis of breast cancer clinical cohorts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.